Search Results - "Ranjarajan, Parthasarathy"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Abstract 6405: Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting Notch signaling

    Abstract 6405: Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting Notch signaling by Weir, Scott James, Dandawate, Prasad, Ramamoorthy, Prabhu, Ranjarajan, Parthasarathy, Wood, Robyn, Brinker, Amanda, Woolbright, Benjamin, Tanol, Mehmet, Ham, Tammy, McCulloch, William, Dalton, Michael, Baltezor, Michael J., Jensen, Roy A., Taylor, John A., Anant, Shrikant

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Ciclopirox (CPX) is a FDA-approved topical antifungal agent that has demonstrated preclinical anticancer activity in solid and hematologic malignancies. It's…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Preclinical development of ciclopirox prodrug for the treatment of non-muscle invasive and muscle invasive bladder cancer

    Preclinical development of ciclopirox prodrug for the treatment of non-muscle invasive and muscle invasive bladder cancer by Weir, Scott James, Wood, Robyn, Ham, Tammy, Ranjarajan, Parthasarathy, Ramamoorthy, Prabhu, Rajewski, Lian, Heppert, Kathy, Haslam, John, Schorno, Karl, Dalton, Michael, McKenna, Michael J, Reed, Greg, Brinker, Amanda E, McCulloch, William, Baltezor, Michael Jay, Jensen, Roy A., Taylor, John Arthur, Anant, Shrikant

    Published in Journal of clinical oncology (20-05-2018)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: